Position Overview
This pivotal leadership role within the UK Pharma Commercial team leads a multidisciplinary function that shapes the UK's position as a priority destination for global pharmaceutical investment. You will drive the organization’s strategy across NICE, SMC, and AWMSG to maintain commercial viability and patient access.
Responsibilities
* Shape UK pricing and reimbursement strategy across NICE, SMC, and AWMSG.
* Lead high‑stakes negotiations for Commercial Access Agreements to protect and grow a billion‑pound revenue stream through sustainable, innovative funding models.
* Influence government policy and maintain strategic relationships with the Department of Health and Social Care, HM Treasury, and the broader political landscape.
* Build a world‑class Access engine that serves as the gold standard for the global headquarters.
* Drive health equity and system transformation by leading initiatives that improve patient outcomes, enhance population health, and reduce per‑capita costs in partnership with the NHS.
* Pioneer innovative access models, including outcome‑based agreements, value‑based pricing, and real‑world evidence frameworks that can be exported globally.
Qualifications
* Extensive senior leadership experience in market access, health economics, or government affairs within the pharmaceutical or life sciences sector.
* Deep expertise in UK HTA processes and the commercial mechanics of industry‑government pricing frameworks.
* Proven political advocate, comfortable engaging at ministerial and senior civil servant level to shape policy outcomes.
* Enterprise thinker who balances access decisions against commercial, medical, and supply chain considerations across a complex portfolio.
* Leads with purpose, translating strategic patience into tactical urgency to deliver patient access today while building frameworks for tomorrow.
Preferred Experience
* Experience navigating the post‑Brexit regulatory and trade landscape as it impacts pharmaceutical operations.
* Background in Real‑World Evidence generation and its application to HTA submissions and lifecycle management.
* International or global headquarters experience demonstrating cross‑market strategic influence.
Equal Opportunity & Diversity Statement
At Roche Products we believe diversity drives innovation and we are committed to building a diverse and flexible working environment. All qualified applicants will receive consideration for employment without regard to race, religion or belief, sex, gender reassignment, sexual orientation, marriage and civil partnership, pregnancy and maternity, disability or age. We recognise the importance of flexible working and will review all applicants’ requests with care. At Roche difference is valued and we are proud to be an equal opportunity employer where you are encouraged to bring your whole self to work.
#J-18808-Ljbffr